Shanghai Fosun Pharmaceutical's (HKG:2196, SHA:600196) unit Hebei Wanbang Folon Pharmaceutical obtained approval for the registration application of Shaoyao Gancao Tang Granules from China's National Medical Products Administration.
The drug is used for various spasm and pain conditions caused by insufficiency of yin and blood and malnourishment of the sinews and vessels that manifests as leg and feet spasms and
abdominal pain, according to a Monday filing.